Market
Scenario:
Eye cancers or ocular cancers manifests itself in
the eye. Cancer is referred to the uncontrolled growth of the cells, similarly,
eye cancer occurs when healthy cells in or around the eye change and grow
uncontrollably leading to the formation of tumors. The global eye cancer market
is expecting a healthy growth in coming future. The global market is majorly
driven by increasing eye cancer patients across the globe. Additionally,
increasing smoking population and rising consumption of alcohol have spurred
the growth of the market. However, long time for approval, and side effects of
the treatment may hinder the growth of the market.
The
global eye cancer market is expected to grow at a CAGR of ~8.3 % during the
forecast period 2017-2023.
Key
Players
Some of key
the players in the market are Novartis AG
(Switzerland), Spectrum Pharmaceuticals Inc. (U.S.), GlaxoSmithKline Plc.
(U.K.),Bayer AG (Germany), Amgen, Inc. (U.S.), Bristol-Myers Squibb
Company (U.S.), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K.), F.
Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.),
Sanofi (France), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan),
Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Oncomed Pharmaceuticals
(U.S.) and Immunomedics (U.S.).
Segmentation
The
global eye cancer market is segmented on the basis of types, treatment and end
users.
On the
basis of types, the market is segmented into intraocular cancer, squamous cell
cancer, rhabdomyosarcoma, and others. Intraocular cancer is further segmented
into melanoma of the eye, lymphoma of the eye, and eye cancers in children.
On the
basis of treatment, the market is categorised into chemotherapy, surgery &
radiation therapy, targeted therapy, hormone therapy, biologic therapy, and
other. Chemotherapy is further segmented into anthracyclines, taxanes,
antimetabolites, and alkylating agents. Target therapy is sub segmented into
monoclonal antibodies and tyrosine kinase inhibitors. Hormone therapy is
further segmented into selective estrogen-receptor modulators (SERMs),
aromatase inhibitors and others.
On the
basis of end users, the market is segmented into hospital & clinics,
ambulatory care centers and others.
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
Chapter 3. Research Methodology
3.1
Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
Chapter 4. Market Dynamics
4.1
Drivers
4.2
Restrains
4.3
Opportunities
4.4
Challenges
4.5
Macroeconomic Indicators
4.6
Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1
Porters Five Forces Analysis
5.1.1
Bargaining Power Of Suppliers
5.1.2
Bargaining Power Of Buyers
5.1.3
Threat Of New Entrants
5.1.4
Threat Of Substitutes
5.1.5
Intensity Of Rivalry
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment